Venturepharm Asia

Venturepharm Asia is a leading integrated life science company and service provider based in China, operating under a unique "Full Service Plus" model. This model combines venture capital and merchant banking with comprehensive contract research (CRO), manufacturing (CMO), and sales (CSO) services. The company focuses on a wide range of therapeutic areas, including central nervous system (CNS) disorders, oncology, respiratory diseases, and diabetes. With significant R&D and manufacturing bases in Beijing, Hainan, and Taizhou, Venturepharm Asia supports the entire drug development lifecycle from discovery to commercialization. The group has established numerous partnerships and joint ventures to bridge the pharmaceutical markets between China and the West.